Browse All

Current Filters

CLEAR FILTER x

TITLE

Changing Treatment Trends for MS Patients Recently Initiated on Their First DMT

Author:McFadden, Emma   

Session Name:P12: MS COVID and Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P12.012  

Author Institution:Spherix Global Insights, Exton, PA, PA  

Cerebral Vasculitis in a patient receiving Risankizumab, an Inhibitor of Interleukin-23: First Case Report

Author:Cabrera Pulla, Juan   Amirjanyan, Hasmik   Wu, Qian   Mui, Gracia   Imitola, Jaime   Coban, Hamza   

Session Name:P12: MS COVID and Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P12.013  

Author Institution:University of Connecticut, Hartford, CT  University of Connecticut, West Hartford, CT  University of Connecticut, Farmington , CT  University of Connecticut, Farmington, CT  

High-dose cyclophosphamide as a rescue treatment for fulminant Marburg multiple sclerosis: A case report

Author:Roberts, Matthew   Abdullah, Muhammad   Shoga, Amy   Reyna, Tania   Parker, Alicia   

Session Name:P12: MS COVID and Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P12.014  

Author Institution:University of Texas Health San Antonio, San Antonio, TX  Joe R. & Teresa Lozano Long School of Medicine, San Antonio, TX  

Multiple Sclerosis Related Trigeminal Neuralgia – Clinical Characteristics, MRI Correlates and Treatment Outcomes

Author:Germaine, Sarah   Steiner, Sheila   Rose, John   

Session Name:P12: MS COVID and Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P12.015  

Author Institution:Department of Neurology, University of Utah, Salt Lake City UT, USA, Salt Lake City, UT  Nevada, Idaho, Utah Chapter of the National MS Society , Salt Lake City , UT  Department of Neurology, University of Utah, Salt Lake City UT, USA, Salt Lake City , UT  

A Familial Cohort of Adult-Onset Alexander Disease

Author:Wolf, Laura   Gettings, Edward   Goodrich, Louis   

Session Name:P12: MS COVID and Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P12.016  

Author Institution:Temple University Hospital, Philadelphia, PA  Lewis Katz School of Medicine at Temple University, Philadelphia, PA